Preclinical models of infectious diseases - task area a and c
Active Awarded Last action
- Contract number
- 75N93024D00009
- Awardee
-
Colorado State University UEI LT9CXX8L19G1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $1,002,594 obligated
Award facts
- Opportunity
-
- Pre-Clinical Models of Infectious Diseases Pre-Solicitation · NIHAI75N93023R00003 · Posted Oct 21, 2022
- Combined order value
-
- $1,002,594 Current, with exercised options
- $2,788,422 Potential, with all options
- Last date to order 33% complete
- IDV ceiling 1% used
- $146,300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 76 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite delivery contract to Colorado State University on July 15, 2024, with a ceiling value of $146.3 million and an ultimate completion date of July 14, 2031. No set-aside was used.
Work is performed in Fort Collins, Colorado. The IDIQ procures preclinical animal models of infectious diseases across three task areas: small animal models, non-human primate models, and animal replacement and non-traditional animal models. The contract supports NIAID's mission to understand, treat, and prevent infectious diseases with pandemic potential and antimicrobial resistant infections.
The originating pre-solicitation was posted on October 21, 2022, with a due date of November 7, 2022.
Recent delivery orders issued under this IDIQ include a June 2, 2026 order for model development and in vivo screening of antivirals directed against select togaviruses, valued at $993,995 with a cost no-fee pricing structure and completion date of June 1, 2027. An earlier delivery order issued on September 2, 2024 supports collection of metadata from in vivo studies performed under previous IDIQ contract mechanisms, priced on a firm fixed price basis at $56,795.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93024D00009?
75N93024D00009 was awarded to Colorado State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.
How much is contract 75N93024D00009 worth?
Orders under 75N93024D00009 have obligated $1,002,594. Their combined potential value, with all options, is $2,788,422. 75N93024D00009's own ceiling is $146,300,000.
How many orders have been placed under contract 75N93024D00009?
3 orders have been placed under 75N93024D00009, the latest on June 2, 2026.
Who can order from contract 75N93024D00009?
75N93024D00009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93024D00009 part of a contract vehicle?
Yes. 75N93024D00009 is part of Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024D00009 competed?
The extent of competition for 75N93024D00009 was full and open competition. The government received 76 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV